Objective:Prostate cancers (PCa) in Asian individuals are molecularly distinct from those found in their Caucasian counterparts.There is no risk stratification tool for Asian men with rapid biochemical recurrence (BCR) following radical prostatectomy (RadP).This study aims to assess the detection rate of 68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT) for diagnosis of clinical recurrence and as a treatment decision making tool in Asian patients with BCR post-RadP.Methods:68Ga PSMA-PET and CT body with/without bone scan [conventional workup (CWU)] were performed in 55 Asian patients with BCR within 36 months post-RadP.Two blinded reviewers assessed the images.Detection rates of 68Ga PSMA-PET/CT were evaluated,and impact on management was reviewed by comparison with CWU.Results:Median time to BCR post-RadP was 8.1 months.Detection rate for 68Ga PSMA-PET/CT was 80％ (44/55).A positive scan was significantly associated with increasing prostate-specific antigen (PSA) level [odds ratio (OR) =1.13 (95％ CI 1.05-1.30),P =0.017],but not with higher Gleason grade or shorter PSA doubling time.Compared to CWU,68Ga PSMA-PET/CT detected an additional 106 lesions in 33/44 patients with a positive scan,resulting in a change in management in 25/44 (56.8％) patients:10 to hormonal therapy (HT) and whole pelvis radiotherapy (RT) in addition to bed RT,and 15 to palliative HT alone.Conclusions:In the present report,we demonstrated the diagnostic and treatment decision utility of 68Ga PSMA-PET/CT in Asian men with rapid BCR.Detection of small volume nodal and systemic recurrences at low PSA levels (＜ 1.0 ng/mL) highlights the role of the tool in assigning patients to treatment intensification with HT-RT or palliative HT in polymetastatic disease.